Rif. 5379 - Innovative Approaches To Diagnosis, Monitoring And Treatment Of Lymphomas And Chronic...

Universities and Institutes of Italy

Italy

October 7, 2022

Description

  • Organisation/Company: ALMA MATER STUDIORUM - Università di Bologna
  • Research Field: Medical sciences
  • Researcher Profile: First Stage Researcher (R1) Recognised Researcher (R2) Established Researcher (R3) Leading Researcher (R4)
  • Application Deadline: 07/10/2022 23:59 - Europe/Brussels
  • Location: Italy › Bologna
  • Type Of Contract: Temporary
  • Job Status: Other
  • Innovations in the field of lymphomas and chronic lymphoproliferative syndromes mainly rely on: a) survival improvement in patients with multiply treated relapsed and refractory disease; b) detection and quantification of minimal residual disease after an effective treatment. The contexts in which these innovative approaches will be explored are: a) immunotherapy with bispecific antibodies in patients with heavily pretreated B-cell lymphomas; b) medium and long-term efficacy and safety of chimeric antigen receptor (CAR) T-cells in both approved and novel settings of application; c) detection of minimal residual disease by monitoring the BRAFV600E mutation in patients with hairy cell leukemia and correlation with overall survival and time to any next treatment.

    Required Research Experiences
  • RESEARCH FIELD
  • Medical sciences

  • YEARS OF RESEARCH EXPERIENCE
  • 1 - 4

    Offer Requirements
  • REQUIRED EDUCATION LEVEL
  • Medical sciences: PhD or equivalent

  • REQUIRED LANGUAGES
  • ENGLISH: Good

    Contact Information
  • Organisation/Company: ALMA MATER STUDIORUM - Università di Bologna
  • Department: Dipartimento di Medicina specialistica, diagnostica e sperimentale – DIMES
  • Organisation Type: Higher Education Institute
  • Website: https: // bandi.unibo.it/docenti/rtd
  • E-Mail: apos.ricercatoritempodeterminato@unibo.it
  • Country: Italy
  • City: Bologna
  • Similar Jobs

    Add to favorites Read more...

    Post-Doctoral Fellowship - Acute Myeloid Leukemia - Perugia, Italy

    Research Field: Biological sciences › Biology Location: Italy › Perugia biology and treatment of NPM1-mutated acute myeloid leukemia. Unfortunately, most patients diagnosed with NPM1-mutated AML eventually role in the maintenance of the leukemic phenotype of...

    Add to favorites Read more...

    Mechanisms And Role Of Mtor Hyperactivation In Cancer.

    various types of human cancers. advancements on the mechanisms underlying mTOR-driven tumorigenesis, which Eligible destination country/ies for fellows: Eligibility of fellows: country/ies of residence: https: // progetti.unicatt.it/progetti-ateneo-roma-assegni-di-ricerca- Organisation Type: Private with public mission Website: https:...

    Add to favorites Read more...

    Platinum/Parp Inhibitor Resistance And Acquired Vulnerabilities In Ovarian Cancer

    aims to understand how mut-p53 driven metabolic rewiring may sustain in cancer metabolism, and must be familiar with technologies required to Eligible destination country/ies for fellows: Eligibility of fellows: country/ies of residence: https: // web.units.it/concorsi/ricerca/conc-46110...

    Universities and Institutes of Czech

    Czech Republic Sep 22, 2022

    Add to favorites Read more...

    Long Non-Coding Rnas (Lncrnas) In The Pathogenesis Of B Cell Lymphomas

    following project funded by the ERC (European Research Council) Starting Follicular lymphoma (FL) is a type of blood cancer that originates of resistant disease or to the high-grade transformation to a more aggressive Importantly, the...

    Add to favorites Read more...

    Preclinical Development Of An Orexin Receptor Agonist For The Therapy Of Narcolepsy Type 1

    agonist for the therapy of narcolepsy type 1, which is presently in the address: https: // bandi.unibo.it/ricerca/assegni-ricerca Eligible destination country/ies for fellows: Eligibility of fellows: country/ies of residence: https: // bandi.unibo.it/ricerca/assegni-ricerca Organisation Type: Public Research...